Evidence map›Paper›PMID 28012062›Full record

ArticleMolecular biotechnology2017

A Synthetic Hybrid Promoter for Xylose-Regulated Control of Gene Expression in Saccharomyces Yeasts.

Ronald E Hector, Jeffrey A Mertens

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Regulation of Transgene Expression by the Natural Sweetener Xylose.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article
  6. Article
  7. Review
  8. Review
  9. D-Xylose Sensing inInternational journal of molecular sciences · 2021
    Review
  10. Biology · 2021
    Review
  11. Review
  12. In vivo biosensors: mechanisms, development, and applications.Journal of industrial microbiology & biotechnology · 2018
    Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Ronald E HectorBioenergy Research Unit, National Center for Agricultural Utilization Research, USDA-Agricultural Research Service, 1815 N. University Street, Peoria, IL, 61604, USA. ronald.hector@ars.usda.gov.
Jeffrey A MertensBioenergy Research Unit, National Center for Agricultural Utilization Research, USDA-Agricultural Research Service, 1815 N. University Street, Peoria, IL, 61604, USA.
Agricultural Research Service · USNational Center for Agricultural Utilization Research · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolism of non-glucose carbon sources is often highly regulated at the transcriptional and post-translational levels. This level of regulation is lacking in Saccharomyces cerevisiae strains engineered to metabolize xylose. To better control transcription in S. cerevisiae, the xylose-dependent, DNA-binding repressor (XylR) from Caulobacter crescentus was used to block transcription from synthetic promoters based on the constitutive Ashbya gossypii TEF promoter. The new hybrid promoters were repressed in the absence of xylose and showed up to a 25-fold increase in the presence of xylose. Activation of the promoter was highly sensitive to xylose with activity seen at concentrations below 2 μM xylose. These new xylose-inducible promoters allow improved control of gene expression for engineered strains of Saccharomyces yeasts.

Indexed as

Caulobacter crescentusCloning, MolecularGene Expression Regulation, BacterialGenes, SyntheticPromoter Regions, GeneticRepressor ProteinsSaccharomyces cerevisiaeSynthetic BiologyTranscription, GeneticXyloseRepressor ProteinsXyloseCaulobacter crescentusGene regulationPromoterSaccharomycesXylose inducible

Identifiers

PMID28012062
OpenAlexW2562243586

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.